Search research articles
Contact Us
Filters
Showing results (311-320 of 1,623) with videos related to
Page
of 163
Sort By:
Archives of Internal Medicine
|
July 26, 2006
"Therapeutic intent" in phase 1 oncology trials: a justifiable objective
Maurie Markman
Gynecologic Oncology
|
May 29, 2007
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2007
Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action
Maurie Markman
Gynecologic Oncology
|
February 13, 2010
"Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer"
Maurie Markman
Gynecologic Oncology
|
February 20, 2010
"Clinical benefit rate" in phase 2 gynecologic cancer trials: implying more than the data support?
Maurie Markman
Gynecologic Oncology
|
July 25, 2018
Response to: "Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomastis (Chua TC, et al.)"
Maurie Markman
Cancer Investigation
|
December 27, 2005
Reflections on ethical concerns arising from the incorporation of results of randomized trials of antineoplastic therapy into routine clinical practice
Maurie Markman
Cancer
|
October 11, 2008
Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2005
Use of positron emission tomography scans in ovarian cancer: a diagnostic technique in search of an indication
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2007
Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
Maurie Markman
Page
of 163
Search research articles
Search
Showing results (311-320 of 1,623) with videos related to
Sort By:
Page
of 163
Archives of Internal Medicine
|
July 26, 2006
"Therapeutic intent" in phase 1 oncology trials: a justifiable objective
Maurie Markman
Gynecologic Oncology
|
May 29, 2007
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2007
Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action
Maurie Markman
Gynecologic Oncology
|
February 13, 2010
"Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer"
Maurie Markman
Gynecologic Oncology
|
February 20, 2010
"Clinical benefit rate" in phase 2 gynecologic cancer trials: implying more than the data support?
Maurie Markman
Gynecologic Oncology
|
July 25, 2018
Response to: "Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomastis (Chua TC, et al.)"
Maurie Markman
Cancer Investigation
|
December 27, 2005
Reflections on ethical concerns arising from the incorporation of results of randomized trials of antineoplastic therapy into routine clinical practice
Maurie Markman
Cancer
|
October 11, 2008
Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2005
Use of positron emission tomography scans in ovarian cancer: a diagnostic technique in search of an indication
Maurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2007
Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
Maurie Markman
Page
of 163